Inactive Instrument

All News RayzeBio, Inc.

Equities

RYZB

US75525N1072

All News

Unlock all the news: Be the first to know and act before the market!

Certain Preferred Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
Certain Stock Options of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
Certain Common Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
RayzeBio, Inc.(NasdaqGM:RYZB) dropped from S&P TMI Index	02-27	CI
Bristol-Myers Squibb Completes RayzeBio Acquisition	02-26	MT
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer	02-26	AQ
Bristol Myers: acquisition of RayzeBio finalized	02-26	CF
Rayzebio, Inc. Announces Executive Changes	02-26	CI
RayzeBio, Inc.(NasdaqGM:RYZB) dropped from NASDAQ Composite Index	02-25	CI
Bristol-Myers Squibb Company completed the acquisition of RayzeBio, Inc..	02-25	CI
Wall Street: in the green after a euphoric Thursday	02-23	CF
Bristol Myers Squibb Says RayzeBio Shareholders Overwhelmingly Accept $4.1 Billion Buyout Offer	02-23	MT
Wall Street: stabilization in sight after a euphoric Thursday	02-23	CF
Bristol Myers Wraps RayzeBio Tender Offer with 86% of Shares	02-23	DJ
Bristol Myers: successful takeover bid for RayzeBio	02-23	CF
PeptiDream to Partake in Bristol Myers' Tender Offer for All RayzeBio Shares	02-15	MT
Bristol Myers Squibb Reportedly Eyeing $13 Billion from Bond Sale Launched Wednesday	02-14	MT
Bristol-Myers Squibb, RayzeBio Say Hart-Scott-Rodino Act Waiting Period Expires	02-12	MT
Bristol Myers: HSR period expires for RayzeBio	02-12	CF
Scion Life Sciences Launches with Oversubscribed $310 Million Fund to Create and Build Exceptional Biotech Companies	02-08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News RayzeBio, Inc.

Equities

RYZB

US75525N1072

All News

Filters